Gene therapy for Oculopharyngeal muscular dystrophy - Archive ouverte HAL
Communication Dans Un Congrès Année : 2018

Gene therapy for Oculopharyngeal muscular dystrophy

Fichier non déposé

Dates et versions

hal-04011201 , version 1 (02-03-2023)

Identifiants

  • HAL Id : hal-04011201 , version 1

Citer

Capucine Trollet. Gene therapy for Oculopharyngeal muscular dystrophy. 11th Japanese-French Workshop “New insights in personalized medicine for neuromuscular diseases: From Basic to Applied Myology”, Jun 2018, Tokyo, Japan. ⟨hal-04011201⟩
18 Consultations
0 Téléchargements

Partager

More